at CNBC.com (Nov 2, 2014)
Smith & Wesson (SWHC) posts a mixed FQ2, meeting EPS estimates but missing on revenue. Gross profit was 26.7% of sales, down from 30.4% for the year-ago quarter, reflecting the impact of costs associated with a product recall as well as the consolidation of its Thompson/Center Arms business to Springfield, Massachusetts. The company also lowers guidance, now expecting FQ3 sales to be between $92M - $96M, below Street estimates of $101M. Shares -1.8% AH.
From other sites